Physician profile
William L Newcomb
NPI 1871519116
$15,228.61
in general payments reported to CMS, 2019-2025
12 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,305 · 2020: $6,109 · 2021: $3,469 · 2022: $1,524 · 2023: $310 · 2024: $356 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $822.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $821.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,061.56 | 2019-2024 | |
| Davol INC. | $2,409.84 | 2019-2025 | Phasix Mesh |
| Hitachi Healthcare Americas Corp. | $180.72 | 2019 | |
| Acell, INC. | $172.20 | 2019-2020 | |
| Stryker Corporation | $168.42 | 2019-2021 | |
| Mentor Worldwide LLC | $86.10 | 2020 | |
| Allergan, INC. | $66.09 | 2019-2020 | |
| Kerecis Limited | $27.27 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Portola Pharmaceuticals, LLC | $20.85 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $17.83 | 2019 | |
| Zimmer Biomet Holdings, INC. | $17.73 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Newcomb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.